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Haploinsufficiency of HDAC4 Causes Brachydactyly
Mental Retardation Syndrome, with Brachydactyly
Type E, Developmental Delays, and Behavioral Problems
Stephen R. Williams,1 Micheala A. Aldred,3 Vazken M. Der Kaloustian,4,6 Fahed Halal,5
Gordon Gowans,7 D. Ross McLeod,8 Sara Zondag,9 Helga V. Toriello,9 R. Ellen Magenis,10
and Sarah H. Elsea1,2,*
Brachydactyly mental retardation syndrome (BDMR) is associated with a deletion involving chromosome 2q37. BDMR presents with
a range of features, including intellectual disabilities, developmental delays, behavioral abnormalities, sleep disturbance, craniofacial
and skeletal abnormalities (including brachydactyly type E), and autism spectrum disorder. To date, only large deletions of 2q37 have
been reported, making delineation of a critical region and subsequent identification of candidate genes difficult. We present clinical
and molecular analysis of six individuals with overlapping deletions involving 2q37.3 that refine the critical region, reducing the candi-
date genes from>20 to a single gene, histone deacetylase 4 (HDAC4). Driven by the distinct hand and foot anomalies and similar cognitive
features, we identified other cases with clinical findings consistent with BDMR but without a 2q37 deletion, and sequencing of HDAC4
identified de novo mutations, including one intragenic deletion probably disrupting normal splicing and one intragenic insertion that
results in a frameshift and premature stop codon. HDAC4 is a histone deacetylase that regulates genes important in bone, muscle,
neurological, and cardiac development. Reportedly, Hdac4/ mice have severe bone malformations resulting from premature ossifica-
tion of developing bones. Data presented here show that deletion or mutation of HDAC4 results in reduced expression of RAI1, which
causes Smith-Magenis syndrome when haploinsufficient, providing a link to the overlapping findings in these disorders. Considering
the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4
in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.Introduction
Chromosome deletions involving the 2q37 region result
in brachydactyly mental retardation syndrome (BDMR
[MIM 600430]), also known as Albright hereditary osteo-
dystrophy-like syndrome (AHO-like). BDMR is a complex
disorder that presents with a spectrum of clinical features,
including developmental delay, obesity, autism spectrum
disorder, and craniofacial and skeletal abnormalities,
including brachydactyly type E in approximately 50% of
cases.1,2 Cardiac defects are reported in ~20% of cases,1
and behavioral problems and neurological anomalies are
common.3–5 The deletion 2q37 syndrome phenotype
consists of a variety of findings that overlap with other
syndromes, including Smith-Magenis (SMS [MIM
182290]), Prader-Willi (PWS [MIM 176270]), Angelman
(AS [MIM 105830]), and fragile-X (FRAX [MIM 300624])
syndromes.
Approximately 100 individuals have been reported
with a deletion involving the chromosome 2q37 region.2
Genotype:phenotype correlations have been attempted
in the past but have failed to identify a single gene that
may contribute to the core findings observed in BDMR.1Department of Human and Molecular Genetics, Virginia Commonwealth U
Pediatrics, Virginia Commonwealth University School of Medicine, Richmon
Cleveland Clinic, Cleveland, OH 44195, USA; 4Department of Pediatrics, The
1P3, Canada; 5Division of Medical Genetics, The Montreal Children’s Hospita
Human Genetics, McGill University, Montreal, Quebec H3H 1P3, Canada; 7W
Louisville, Louisville, KY 40202, USA; 8Department of Medical Genetics, Un
Spectrum Health, Grand Rapids, MI 49503, USA; 10Department of Genetics, O
*Correspondence: selsea@vcu.edu
DOI 10.1016/j.ajhg.2010.07.011. 2010 by The American Society of Human
The AmericRefining the critical region for deletion 2q37 syndrome
has proven difficult because of poor genotype:phenotype
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would help define minimal overlapping candidate regions.
To date, the critical region for this syndrome has not been
clearly defined, and a variety of phenotypes have been
mapped to the 2q37.1/2qter region.2 Variable expres-
sivity and reduced penetrance for most major features
complicate genotype:phenotype correlations in this syn-
drome and further impair diagnosis.
In a study of 52 individuals referred for a phenotype
consistent with Smith-Magenis syndrome (SMS) for whom
no 17p11.2 deletion or RAI1 (MIM 607642) mutation
could be found, we identified by whole-genome array
comparative genomic hybridization (aCGH) several copy
number variants responsible for the SMS-like phenotypes
observed in these individuals.6 Interestingly, we identified
two cases that carried overlapping deletions of the 2q37
region.6 After a literature review, we discovered that the
phenotypic overlap between these two distinct syndromes
was striking. Utilizing this unique aCGH data set and addi-
tional cases, we refined the critical region for BDMR,
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(MIM 605314). Given the apparent phenotypic overlap
between SMS and BDMR, we then investigated more
closely the specific phenotypes in our cohorts with
Smith-Magenis syndrome-like and/or AHO-like features
and identified two subjects who lacked a 2q37 deletion
but had striking phenotypic overlap with known 2q37
deletion cases. Sequencing of the coding region of
HDAC4 in each of these cases revealed de novo mutations.
Studies show that HDAC4 (histone deacetylase 4) is critical
for proper skeletogenesis and chondrogenesis,7 as well as
neuronal survival.8 Taking into consideration the overlap-
ping deletion data and de novo mutations presented here,
we assert that haploinsufficiency of HDAC4 results in the
brachydactyly mental retardation syndrome.Material and Methods
Subject Ascertainment
Subjects were not formally recruited. Samples and medical records
were ascertained after informed consent was obtained by referral
based on suspicion of Smith-Magenis syndrome or AHO-like
features. Subjects were referred to the S.H.E. laboratory for molec-
ular evaluation of SMS at Michigan State University or Virginia
Commonwealth University or to the M.A.A. laboratory at the
Cleveland Clinic for AHO-like phenotype. Samples and medical
records were collected in accordance with Institutional Review
Board-approved protocols from the appropriate institution.
Peripheral blood was collected, and DNA and metaphase chromo-
somes were prepared according to standard methods. Phenotypic
informationwas collected frommedical records, geneticist reports,
and patient photos.
Genomic DNA Sequence Analysis
Total DNA was isolated from cultured peripheral white blood
cells with the QIAamp DNAMinikit (QIAGEN, Hilden, Germany).
PCR was performed with intronic primers from the HDAC4 gene
generated with Primer3 (v. 0.4.0), which flank both the 50 and 30
regions of each HDAC4 exon (Table S1 available online). PCR
products were treated with ExoSAP-IT (USB, Cleveland, OH) to
digest PCR primers. Sequencing and analysis of electropherograms
were done as previously described.9 PCR products were sequenced
and analyzed on both the forward and reverse DNA strands.
Sequencing primers are provided in Tables S1 and S2.
SMS245 Allele Cloning
PCR products from SMS245 coding exon 4 were excised from 2%
agarose gel and DNA isolated with QiaQuick kit (QIAGEN, Hilden,
Germany). PCR products were then cloned into a StrataClone PCR
Cloning vector via standard TA cloning techniques and protocol
provided by the manufacturer (Agilent Technologies, Santa Clara,
CA). Plasmid DNA was isolated with Fermentus GeneJET plasmid
mini kit (Burlington, Ontario, Canada) according to standard
manufacturer’s instructions. Sequences were confirmed with
vector primers and standard Sanger sequencing techniques.
Multiplex Ligation-Dependent Probe Amplification
and SNP Array Analysis
MLPA was performed as previously described10 with five custom-
designed probe sets that were approximately equally spaced across220 The American Journal of Human Genetics 87, 219–228, August 1the genomic extent of HDAC4 (Table S3). Breakpoints outside of
the HDAC4 gene were defined with Illumina CNV370 single
nucleotide polymorphism arrays and Beadstudio software to iden-
tify copy number changes.
Quantitative Real-Time PCR
RNA was isolated from cultured patient and control lymphoblas-
toid cell lines or lymphocytes collected from blood via Trizol
(Invitrogen, Carlsbad, CA) according to standard protocols. All
cell lines were cultured for the same period of time to the same
cell density, and all samples were processed in the same manner.
Quantitative reverse transcriptase real-time PCR was performed as
previously described11 via Taqman probes (Applied Biosystems,
Foster City, CA) for GAPDH (MIM 138400, internal control),
HDAC4, or RAI1. Control RNAs for real-time PCR assays came
from ‘‘like’’ samples, i.e., whole bloodor cultured cells, as described,
and at least two different control samples were analyzed for each
expression assay to ensure expression data were consistent.Results
As listed and described in Table 1, common features of
BDMR include mild facial dysmorphism, congenital heart
defects, distinct brachydactyly type E (BDE), intellectual
disabilities, developmental delay, seizures, autism spec-
trum disorder, and obesity.1,2 By utilizing recent studies
of SMS-like6 and known deletion 2q37 subjects,1 we were
able to make genotype:phenotype correlations allowing
refinement of the critical region for BDMR to ~chr2:
239,639,900-240,938,547 within the 2q37.3 band,
including the HDAC4 gene (Figure 1).
Refinement of the BDMR Critical Region
Because the deletions we identified map to a small overlap-
ping region within the 2q37.3 band,1,6 we were able to
narrow the critical region to ~200 kb region including
HDAC4 (Figure 1), with SMS272 critical to this analysis re-
sulting from the very small deletion identified by aCGH.
SMS272 carries a small, 1.17 Mb, 2q37.3 deletion
(Figure 1).6 She is an obese Native American with cognitive
and developmental delays who was originally referred for
features of Smith-Magenis syndrome (SMS).6 Skeletal
features include brachydactyly type E (shortened 3rd, 4th,
and 5th metacarpals with shortened and proximately
paced 4th left toe), midface hypoplasia, and brachycephaly
(Figure 2, Table 1). She also exhibits stereotypies and
aggressive behavior but lacks two of the key features, sleep
disturbance and self-abusive behavior, which are common
in SMS. SMS320, who was also referred for an SMS-like
phenotype,6 carries a larger deletion of 2q37.3 that spans
3.02 Mb (Figure 1) and was referred for developmental,
speech, and motor delays, sleep disturbance, stereotypies,
attention seeking, and self-injurious behaviors. Her cranio-
facial and skeletal phenotype consists of brachydactyly,
brachycephaly, midface hypoplasia, tented upper lip, and
a broad, square face (Table 1).
Two del(2)(q37.3) subjects were analyzed by MLPA to
assess the specific location of the breakpoints observed3, 2010
Table 1. Clinical Features of Cases with Deletions or Mutations Involving 2q37.3
Phenotype
SMS117 HDAC4
Mutation
(c.2399_2400insC)
SMS245 HDAC4
Mutation
(c.490þ56_121 del65)
SMS272 del(2)(q37.3)
Including HDAC46
SMS320 del(2)(q37)
Including HDAC46
122del(2)(q37)
Including HDAC41
10780 del(2)(q37)
Including HDAC43
2282 del(2)(q37.3)
Not Including HDAC4
(current study)
Sex F F F F F F F
Age at evaluation 16 and 25 years 10 and 16 years 15 and 17 years 3 years 6 years 12 years 7 years
Developmental delay þ þ þ þ þ þ þ
Motor delay þ þ - þ þ þ þ
Language impairment þ þ þ þ þ þ þ
Behavioral problems self-injurious behavior;
pulling out of fingernails
self-injurious behavior;
skin picking; aggression
aggressive behavior;
hand wringing;
eye squint
self-injurious behavior;
head banging; skin picking;
hand biting; hyperactivity
receptive language
and social
communication disorders
N/A autistic behavior;
repetitive
behaviors
Stereotypies N/A þ self-hug, tics self-hug N/A N/A N/A
Sleeping difficulties þ þ - þ N/A N/A N/A
Decreased sensitivity to pain þ þ þ þ N/A N/A N/A
Hearing loss þ - N/A - - - -
Short stature þ/ þ - - þ þ -
Seizures essential tremor - - - - þ þ
Feeding difficulties þ - - - - N/A -
Obesity/overweight þ þþ þ þ - - þ
Craniofacial manifestations
Broad face þ þ þ þ þ þ þ
Upslanting eyes þ þ þ þ - - N/A
Brachycephaly þ - þ þ N/A N/A N/A
Midface hypoplasia þ - þ þ N/A þ þ
Broad, upturned nose þ broad, not upturned þ þ N/A þ -
Skeletal abnormalities
Brachydactyly, type E þ þ, mild þ N/A þ þ -
Proximally placed 4th toe,
shortened 4th metatarsal
þ N/A þ - þ þ -
Other subvalvar aortic stenosis;
mitral stenosis; pacemaker;
hypothyroidism; hirsuitism;
spina bifida occulta;
very friendly
small chin; narrow
palpebral fissures;
constipation;
hypermobility;
bitemporal narrowing;
dental anomalies
sinus arrhythmia;
myopia;
very friendly
2-3 toe syndactyly craniosynostosis hypothyroidism;
precocious puberty
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Figure 1. Delineation of the BDMR Critical Region
(A) Ideogram of chromosome 2 band q37.3.
(B) Schematic representation of 2q37.3 region and RefSeq Genes included.
(C) Horizontal bars indicate the regions of deletion in each of these key 2q37 deletion syndrome cases. The brachydactyly mental
retardation syndrome critical region is indicated by the vertical bars. The SMS117 HDAC4 point mutation is indicated by the small
vertical line. The SMS245 HDAC4 intronic deletion is indicated by the small vertical line.
(D) Quantitative real-time PCR of mRNA from lymphoblastoid cell lines from subject 2232 (del2q37.3 including HDAC4) and subject
2282 (del2q37.3 not includingHDAC4) relative to control subject (noHDAC4mutation or deletion). Assay performed twice in triplicate.
Bars represent standard deviation from the mean. Data show ~50% reduction in HDAC4 expression in 2232 and no change in 2282.(Table 1; Figure S1). As shown in Figure 1, the proximal
breakpoints of the deletions are within the HDAC4 gene.
The breakpoint identified in case 122 is in the second
intron of HDAC4 (3.21 Mb deletion of 2q37), whereas
the breakpoint for case 10780 is in intron 9 (3.2 Mb dele-
tion of 2q37) (Figure 1; Figure S1). Both deletions should
result in haploinsufficiency for HDAC4 because the
promoter and initial coding exons are deleted in both cases
(HDAC4 is transcribed on the minus strand of DNA).
Subject 122 presented with developmental delay, mild
facial dysmorphism, brachydactyly type E, and receptive
language and social communication disorder. Case 10780
presented with developmental delay, short stature, facial
dysmorphism, brachydactyly type E, and grand mal222 The American Journal of Human Genetics 87, 219–228, August 1seizures (Table 1). Detailed clinical descriptions of both
cases have been published previously1,3 (Table 1).
Further supporting the deletion of HDAC4 as responsible
for the brachydactyly type E phenotype is the fact that
subject 2282 has a 2.68 Mb terminal deletion with a break-
point that isdistal ofHDAC4 (Figure1C). This individual pre-
sented with minor craniofacial abnormalities, develop-
mental delay, obesity, autistic behaviors, and a history of
seizures but had no evidence of metacarpal or metatarsal
shortening and no evidence of cardiac or other major organ
defect (Table 1). The phenotype of subject 2282 indicates
that other aspects of 2q37 deletion syndrome are complex
andlikemanydeletion/mutationsyndromes,multiplegenes
may contribute to the full spectrum of the phenotype. An3, 2010
Figure 2. Skeletal Anomalies Observed in BDMR
(A) Hands of case SMS117.
(B) Feet of SMS117, showing shortened 4th metatarsal and wide spacing between toes.
(C) Radiograph of left hand of SMS117 showing shortened 3rd, 4th, and 5th metacarpals.
(D) Radiograph of SMS117 feet showing proximally placed and shortened 4th metatarsal and bilaterally widely spaced 1st, 2nd, and 3rd
toes.
(E) Photo of SMS272 at 17 years of age.
(F) Hands of SMS272. Note shortened 3rd and 4th fingers.
(G) Feet of SMS272 with shortened 3rd toes and proximally placed and shortened 4th toes.
(H) Radiograph documenting shortened 3rd and 4th metacarpals in the hands of SMS272.additional case, subject 2232, was diagnosedwith a terminal
2q37 deletion approximately 7 Mb in size (Figure 1). Unfor-
tunately, no clinical details were available and therefore this
case is not included in Table 1. However, this terminal dele-
tion of chromosomal band 2q37 (including HDAC4) results
in a ~50% reduction in HDAC4 expression (Figure 1D),
whereas the deletion carried by case 2282 (not deleted for
HDAC4) has normalHDAC4 expression, providing evidence
for haploinsufficiency when HDAC4 is deleted.
Thesemolecular andclinical data refined theBDMRcritical
region to a single gene, HDAC4, and supported mutation
analysis of HDAC4 as the logical next step toward identifica-
tion of the causative gene that, when deleted or mutated,
results in BDMR. Further support for the conclusion that
HDAC4 mutations cause BDMR is the Hdac4/ mouse,7
whichhasa significant skeletalphenotype.7Althoughimpor-
tant in electron transport and complex I function in mito-
chondria,NDUFA10 (MIM603835)was eliminated as a prob-
able cause for BDMR given that mitochondrial dysfunction
does not appear to be a key finding in these patients.
HDAC4 Mutation Causes BDMR
Two cases, SMS117 and SMS245, were selected for muta-
tion analysis of HDAC4 because of their phenotypic
overlap with the deletion 2q37 cases discussed above
(Figure 2, Table 1). All coding exons for HDAC4 were
sequenced and assessed for mutation in SMS117 and
SMS245 (PCR primers in Table S1). For SMS117, analysis
of the nucleotide sequence for exon 19 revealed a deThe Americnovo insertion of a single cytosine (c.2399_2400insC;
Figure 3). Because this insertion lies within a run of five
cytosines, the exact location of the insertion cannot be
determined, but this does not impact the resulting location
of the premature stop codon (p.Gly801TrpfsX77) (Fig-
ure 3). This insertion does not confer a reduction in
HDAC4 mRNA expression (Figure 1D), suggesting that
this mutation does not result in significant mRNA decay
and probably produces a nonfunctional HDAC4 protein.
SMS117 is a female French-Canadian born at 43 weeks to
nonconsanguineous parents (Figure 3, Table 1). Birth was
complicated by two induction attempts. Weight at birth
was 2.85 kg (10%–25%) and length was 51 cm (25%–
50%). The first year was marked by feeding difficulties,
and subvalvular aortic stenosis was identified at 4 months.
Psychomotor development was delayed, with walking at
18 months and speaking in sentences at 6 years of age.
The clinical phenotype worsened with age. She received
a mitral valve replacement and permanent pacemaker at
5 years. At 13.5 years, she was referred to genetics where
she presented with dysmorphic features, including mid-
face hypoplasia, broad face and nose, brachycephaly,
frontal bossing, a down-turned lower lip, and upslanted
eyes. Decreased deep tendon reflexes and a wide-based
gate were observed, as was sensorineural hearing loss
(>40 dB) for which she wears two hearing aids. She had
a decreased sensitivity to pain, onychotillomania, hyperac-
tivity, and a decreased attention span. Radiological studies
also revealed cerebral atrophy and spina bifida occulta. Inan Journal of Human Genetics 87, 219–228, August 13, 2010 223
Figure 3. SMS117 HDAC4 Mutation and Impact on HDAC4 Protein
(A) SMS117 at 13 years.
(B) Electropherogram trace showing nucleotide insertion of a single cytosine at c.2399 in the HDAC4 gene.
(C) Partial amino acid alignment of the normal HDAC4 protein with the altered protein probably produced in SMS117 resulting from
frameshift mutation. Premature stop codon highlighted in yellow. The histone deacetylase domain resides at amino acids
655–1084 (blue line) and the nuclear export signal is at amino acids 1051–1084 (orange line). The mutation disrupts the HDAC domain
and removes the nuclear export signal.addition to the admission for heart surgery, she was hospi-
talized for hypersomnolence and precipitous loss of
consciousness. During 44 hr of EEG video telemetry, a
complete absence of REM sleep was noted. Sleep abnormal-
ities began at 3 years of age with several arousals
throughout the night, which lasted until the age of 8 years;
however, at 25 years of age, she could sleep for up to 18 hr
if not awakened. Physical examination at 25 years of age
revealed obesity (96 kg, >95%; 157cm, 10%–25%) and
confirmed the previously described physical and
neurological findings. She had bilateral proximal place-
ment of the 3rd, 4th, and 5th fingers, bilateral proximally
placed 4th toes, and bilateral widely spaced 1st, 2nd, and
3rd toes. Brachydactyly type E was confirmed with
shortened 3rd, 4th, and 5th metacarpals and bilaterally
shortened 4th metatarsals on X-ray (Figure 2). Total hand224 The American Journal of Human Genetics 87, 219–228, August 1length was 14 cm (<3%) and total foot length was
22.5 cm (10%–25%). There is a striking similarity between
the morphology of the hands and feet of SMS117 (HDAC4
mutation) and SMS272 (2q37.3 deletion) (Figure 2),
lending further support to the importance of HDAC4 in
this syndrome. Family history was unremarkable; however,
the patient’s father died at age 50 years of a pulmonary em-
bolism, and no other abnormalities were reported.
Sequencing of the HDAC4 gene in SMS245 included all
coding sequence and known splice sites and identified
a de novo intron 5 deletion of 65 bp at Chr2:239,
763,222-239,763,157 (c.490þ56_121del65) (Figure 4),
probably altering splicing of exons 5–6. These findings
were confirmed by cloning, sequencing, and aligning both
alleles of this region (Figure 4). This finding was not present
in either parent, nor in the Database of Genomic Variants.3, 2010
Figure 4. SMS245 HDAC4 Mutation
(A) SMS245, age 10.
(B) Electropherogram trace showing deletion start of SMS245 HDAC4 intron 5 at bp Chr2:239,763,222 (c.490þ56_121del65).
(C) Alignment of SMS245 normal allele with SMS245 deleted allele. Note 65 bp intronic deletion. Performed with ClustalW accessory
application in BioEdit sequence alignment editor.SMS245 is a 16-year-old intellectually disabled femalewho is
obese,weight152.3kg (þ7 SD)andheight159.8 cm(5th cen-
tile). Shewas born preterm at 35weeks gestation and experi-
enced feeding difficulties during infancy and has chronic
constipation. She has a small chin, large asymmetrically
placed ears, bitemporal narrowing, and narrow palpebral
fissures (Figure 4). Motor activities and speech were delayed
withfirst steps taken at 2.5 years andfirst sentence at 7 years.
Neurological and behavioral abnormalities include aggres-
sive tantrum-like behavior, decreased sensitivity to pain,
head banging, self-biting, skin picking resulting in scarring,
stereotypies, food-seeking behaviors, and sleep disturbance
with multiple nighttime awakenings and daily naps at age
16. Musculoskeletal features include hypotonia, hypermo-
bility, pes planus, and type E brachydactyly with mildly
shortened 3–5 metacarpals and metatarsals. Brachydactyly
type E ranging from absent to severe has been reported in
2q37.3 deletion cases.Figure 5. RAI1 Expression Is Reduced in HDAC4 Deletion and
Mutation Cases
Quantitative real-time PCR of mRNA from lymphoblastoid cells
from subject 2232 (del2q37.3) and SMS117 (HDAC4 mutation)
or lymphocytes from whole blood (SMS245, HDAC4 mutation)
relative to control subjects (no HDAC4 mutation or deletion), as
described in Material and Methods. Assay performed twice in
triplicate. Bars represent standard deviation from the mean.
Control RNA for real-time PCR assays came from ‘‘like’’ samples,
i.e., blood or cultured cells.Effect ofHDAC4Mutation or Deletion onOverlapping
Pathways
Several cases presented here were initially referred for
suspicion of Smith-Magenis syndrome (SMS320, SMS272,
SMS117, and SMS245), which is caused by deletion or
mutation of the retinoic acid induced 1 gene (RAI1). Based
upon the significant phenotypic overlap between BDMR
and SMS, we questioned whether HDAC4 and RAI1 might
function in similar or overlapping molecular pathways
which, when disrupted, lead to similar phenotypic effects,
including sleep disturbances, behavioral problems, obesity,
and craniofacial dysmorphism. As shown in Figure 5, RAI1The Americexpression is reduced in SMS117, SMS245, and subject
2232 (del2q37.3), which indicates that RAI1may function
downstream of HDAC4 and is either directly or indirectly
regulated by HDAC4. These data provide a molecular basis
for the observed phenotypic similarities between these two
disorders.Discussion
We describe six individuals with del(2)(q37.3), five of
which include or interrupt the HDAC4 gene, as well asan Journal of Human Genetics 87, 219–228, August 13, 2010 225
two individuals who have mutations within the HDAC4
gene, pointing to HDAC4 as the primary causative gene
for 2q37 deletion syndrome. Additional cases from the
literature supporting this conclusion include patient 2
from Shrimpton et al. (2004)12 with brachydactyly type
E, short stature, and cognitive delay and a recent report
of a patient with brachydactyly type E, developmental
delay, autism, and seizures (Felder et al., 2009).13 Although
HDAC4 was not specifically examined in these two cases,
the breakpointsmapped in close proximity toHDAC4, sug-
gesting that this gene was probably disrupted. Expression
of HDAC4 was also reduced to ~50% in 2q37.3 deletion
patient cells in the current study. Taken together, we
conclude that haploinsufficiency of HDAC4 results in
brachydactyly mental retardation syndrome.
HDAC4
HDAC4 is a class II HDAC, which acts as a corepressor for
DNA-binding transcription factors. Acting in concert
with HDAC9 and HDAC3, HDAC4 acts to inhibit a variety
of transcription factors, including MEF2C (MIM 600662)
and RUNX2 (MIM 600211), both of which are essential
for proper skeletal development and serve to deacetylate
histones. This deacetylation condenses chromatin, making
it inaccessible to factors that drive transcription. Addition-
ally, class II HDACs are antagonists of cardiac hypertrophy
needed for proper cardiac development.14 Because of this
molecular evidence, it is logical to conclude that deletion
or mutation of HDAC4 would lead to the core phenotypes
seen in BDMR. In addition, it is important to note that all
HDAC4 deletion or mutation cases evaluated for RAI1
expression showed reduced mRNA expression (Figure 5).
This is not surprising given the strong phenotypic overlap
with BDMR and SMS. These data indicate that HDAC4 and
RAI1 function in a common pathway, which, in turn, leads
to common phenotypic effects when disrupted.
Impact of HDAC4 Mutation
The impact of the c.2399_2400insC found in SMS117 on
the HDAC4 protein is significant. The premature stop
codon interrupts the histone deacetylase domain, poten-
tially limiting or preventing all histone deacetylase activity
from this HDAC4 allele. This deacetylase activity is essen-
tial for protein function, as shown by the fact that
HDAC4 has the ability to deacetylate all four core
histones.15 If amino acids 1002–1058 or 803–846 of
HDAC4 (the most conserved domain of HDAC4 across
species) are deleted, interaction with HDAC3 (MIM
605166) and all histone deacetylase activity are elimi-
nated.16 As shown in Figure 3, the insertion of a cytosine
at codon 801 causes a frameshift that significantly reduces
amino acid identity (5%) or similarity (5%) between the
SMS117 mutant and wild-type alleles. Taken together,
these data provide evidence that the mutant HDAC4
protein is completely void of histone deacetylase activity
and can no longer bind with HDAC3. Further, when
mutated from histidine to alanine, a charged polar to226 The American Journal of Human Genetics 87, 219–228, August 1nonpolar change at p.802 and p.803, Fischle et al. (2002)
showed that binding to NCOR1 (MIM 600849) was elimi-
nated.16 NCOR1 is essential for HDAC3 recruitment and
HDAC activity of the complex. The SMS117 mutation of
HDAC4 shows a p.H802T and p.H803P change at these
essential amino acids leading to charged polar to
uncharged polar and charged polar to nonpolar changes,
respectively, potentially having a great impact on the
activity of this mutant protein (Figure 3). Alternatively,
the premature protein truncation might lead to
nonsense-mediated RNA decay and haploinsufficiency.
SMS245 carries a 65 bp de novo deletion in intron 5, which
could result in incorrect splicing of the HDAC4 mRNA
(Figure 4). This splicing error probably leads to RNA decay
and haploinsufficiency of HDAC4.
Hdac4/ and Related Mouse Models
The Hdac4/ mouse exhibits a variety of significant
phenotypes and was shown to have early-onset chondro-
cyte hypertrophy and premature bone ossification.7 These
mice present with severe bone malformations and are
much smaller than wild-type littermates because of prema-
ture ossification of the developing bone. A reflection of the
importance of HDAC4 in bone malformation in humans
can be seen when studying the hands and feet of
SMS117 and SMS272 (Figure 2). In addition, in the same
manuscript by Vega et al. (2004), it was shown that
Hdac4 also directly controls Runt-related transcription
factor 2 (Runx2) activity. The Hdac4/ mouse model
directly mimics the phenotype seen with constitutive
Runx2 expression in chondrocytes.17,18
MEF2C activity, which is necessary for proper chondro-
cyte hypertrophy and bone development, is also regulated
by HDAC4.19,20 Mice deleted for the Mef2c gene have
impaired chondrocyte hypertrophy, cartilage angiogenesis,
ossification, and longitudinal bone growth, a reciprocal
phenotype to that of the Hdac4/ mouse,21 consistent
with HDAC4 acting as a negative corepressor ofMEF2C.
Clinical Implications
In the analysis of 202q37deletion cases, Aldred et al. (2004)
concluded that the region most probably associated with
congenital heart defects in the BDMR syndrome included
the HDAC4 gene.1 In this report, we support this finding
with the fact that SMS117 has a significant cardiac defect.
The role of HDAC4 in cardiac development is further
supportedbydata that implicateMEF2C,which is regulated
by HDAC4, in cardiac development.22 Additional studies
and cases are required to confirm this hypothesis.
Based upon our findings reported here, we conclude that
haploinsufficiency of the HDAC4 gene results in BDMR.
Data support a significant role for HDAC4 in normal
skeletal development, specifically in metacarpal and meta-
tarsal growth and craniofacial development, and in
neuronal function, with a prominent role in behavior.
Autism or autism spectrum disorder (ASD) has been
reported in many cases with 2q37.3 deletions and is3, 2010
consistent with the behavioral and developmental find-
ings in the cases we report here.1,13,23,24 However, two of
our older cases are reported to be ‘‘very friendly’’ but with
poor communication skills, whereas the younger subjects
have significant speech delay and poor communication
with behavioral problems often prohibiting positive inter-
actions. These findings suggest that reduced expression or
function of HDAC4 is a contributor to the ASD phenotype
observed in many cases with 2q37 deletion but that inter-
personal skills may improve with age and with reduction
of negative behaviors. Given that the genetic basis of
autism is highly complex, it is not surprising that autistic
behavior was also reported in case 2282 with a terminal
2q deletion that does not includeHDAC4. This phenotypic
outcome was also found in a published case with a much
smaller subtelomeric deletion, suggesting that multiple
genes at 2q37 may be involved in this phenotype.25
A more proximal locus, CENTG2 at 2q37 (now renamed
AGAP1 [MIM 608651]), has also been suggested by two-
point linkage analysis in autism families, although this
was not supported by multipoint analysis.26
Additionally, a recent publication by Klopocki et al.
(2010)27 has linkedmutations in the parathyroid hormone
related protein (PTHLH [MIM 168470]) to result in brachy-
dactyly type E. Interestingly, Pthlh was identified as an
inhibitor of Runx2 (regulated by Hdac4) in mice,28 and
Pthlh/ mice exhibit lethal short-limbed chondrodyspla-
sia. This finding speaks to the probability of a common
molecular pathway involved in the development of meta-
carpals and metatarsals in the hands and feet in humans.
Given the significant phenotypic overlap with Smith-
Magenis syndrome and the fact that RAI1 expression is
reduced in BDMR cases, BDMR and SMS should be consid-
ered together in the differential diagnosis. Although type E
brachydactyly is unique to BDMR, it is only penetrant in
50%–60% of cases, so its absence does not remove the
possibility of a positive diagnosis for BDMR. Also, other
phenotypes within the BDMR syndrome show variable
expressivity, especially heart defects and behavioral prob-
lems, and this phenotypic variability is commonly
observed among complex behavioral syndromes. Given
the range of phenotypic expression, a genetic ‘‘two-hit’’
model is very probably applicable to these complex neuro-
psychiatric disorders.29 The range of phenotypes and
variable expressivity observed are probably dependent on
deletion size and compounded by other CNVs in the
genome, which is consistent with regard to BDMR. The
diagnostic challenges and the elucidation of core pheno-
types from syndrome to syndrome make it important to
note all molecular findings and detail specific phenotypic
findings in all cases. Gene expression data shown here
support common molecular pathways among these
complex neurodevelopmental disorders and lay the foun-
dation for delineating the etiology behind the common
phenotypes, which will allow for improved diagnosis
and, ultimately, rational therapeutic design for pharmaco-
logical and behavioral interventions.The AmericAs such, we recommend molecular evaluation in cases
with phenotypic findings consistent with BDMR and/or
SMS for deletions involving chromosomes 2q37.3 and
17p11.2, respectively (karyotype, FISH, and/or aCGH).
For those cases without 2q37.3 deletion and with type E
brachydactyly, sequencing of HDAC4 is appropriate. For
those subjects without a deletion of 17p11.2 and without
type E brachydactyly, RAI1 sequence analysis should be
undertaken, and if negative, followed by HDAC4
sequencing. We anticipate additional mutations in the
HDAC4 gene will be identified, lending further support
to this gene playing an essential role in proper cognitive,
bone, and cardiac development in humans.Supplemental Data
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